4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-25-029353
Chief Operating Officer acquired 54,421 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Linscott Walt Addison · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-22 | Grant or award : show line 1 in the form | +54,421 | $2.03 | $110,475 | 54,426 | D |
Loading xslF345X05/ownership.xml…